Quintrio
Home

AGRICULTURAL CHEMICALS

American Vanguard Corporation

AVD

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Last trade $0.7362
Day change -$0.0253 (-3.32%)
Day range $0.734 – $0.824
Volume 443,946
Market cap $23M

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$22.46M
Price / earnings
—
Price / book
0.14×
Price / sales
0.04×
EV / sales
0.41×
EV / EBITDA
7.97×

Profitability

Earnings per share
-$2.03
Return on assets
-9.03%
Return on equity
-36.72%
Dividend yield
0%

Liquidity and leverage

Debt / equity
1.64×
Current ratio
2.02×
Quick ratio
1.12×
Cash ratio
0.39×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$12.59M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for AVD, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$108.38M$116.75M$123.57M$150.69M$119.31M$129.31M$115.8M$165.65M
Cost of revenue$82.12M$82.04M$85.15M$108.08M$85.1M$88.77M$85.61M$142.8M
Gross profit$26.25M$34.71M$38.42M$42.61M$34.21M$40.55M$30.19M$22.84M
Selling, general and administrative$25.8M$26.62M$27.71M$28.64M$26.75M$28.62M$26.63M$32.75M
Research and development$5.34M$6.48M$5.27M$6.02M$5.65M$5.8M$5.68M$7.18M
Total operating expenses$34.14M$35.02M$36.53M$54.73M$40.97M$36.18M$34.5M$93.87M
Operating income-$7.89M-$303K$1.89M-$12.12M-$6.75M$4.37M-$4.31M-$71.03M
Interest expense-$9.15M-$9.13M-$5.79M-$5.34M-$4.92M-$4.45M-$3.77M-$4.56M
Income before taxes-$17.13M-$9.49M-$4.02M-$27.11M-$11.94M-$84K-$8.08M-$77.45M
Income taxes$536K$383K$124K$1.11M$422K$765K$387K$12.98M
Net income-$17.67M-$9.87M-$4.15M-$28.21M-$12.36M-$849K-$8.46M-$90.43M
Net income attributable to common shareholders-$17.67M-$9.87M-$4.15M-$28.21M-$12.36M-$849K-$8.46M-$90.43M
EBITDA-$3.47M$4.32M$7.24M$17.79M-$2.09M$9.21M$439K-$14.87M
Basic earnings per share-$0.61-$0.34-$0.14-$0.99-$0.43-$0.03-$0.30-$3.21
Diluted earnings per share-$0.61-$0.34-$0.14-$0.99-$0.43-$0.03-$0.30-$3.24

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

AVD Shares Fall 6.4% After Q3 Loss Widens Y/Y, Guidance Lowered

American Vanguard Corporation (AVD) reported Q3 2026 results showing a 9% decline in net sales to $108.4 million and a widened loss per share to 61 cents. The company faced headwinds from international weakness, particularly in Central America and Mexico, along with freight cost inflation that compressed gross margins by 450 basis points. Management lowered full-year 2026 guidance and projects Q4 growth, while pursuing strategic acquisitions and product launches to reach $600 million in revenue by late 2028.

The Motley Fool

American Vanguard: 3 Key Takeaways for Long-Term Investors

American Vanguard lowered its full-year 2026 revenue guidance to $500-530 million but is pursuing structural cost reductions through manufacturing consolidation and a 50-product launch target by 2030. The company expects to reach $600+ million in annualized sales by late 2028, though near-term profitability is pressured by rising freight and raw material costs.

Zacks Investment Research

Zacks Initiates Coverage of AVD With Neutral Recommendation

Zacks Investment Research initiated coverage of American Vanguard Corporation (AVD) with a 'Neutral' recommendation. The specialty chemicals manufacturer is implementing restructuring and cost reduction initiatives to improve profitability amid challenging agricultural market conditions. While domestic operations show stability with 6% U.S. revenue growth and a promising product pipeline targeting $100M+ in incremental revenues by 2030, the company faces significant headwinds including elevated debt of $267.6M, weak cash flow, and international market pressures. The stock has declined 80.75% in three months, trading at a significant discount to industry averages.

The Motley Fool

American Vanguard (AVD) Q2 Loss Down 93%

American Vanguard reported Q2 2025 earnings with a narrowed net loss, 1% revenue growth, and improved profitability metrics, signaling early signs of recovery in the agricultural chemicals sector.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Jun 26, 2024$0.03Jul 10, 2024recurring
Mar 26, 2024$0.03Apr 10, 2024recurring
Dec 28, 2023$0.03Jan 12, 2024recurring
Sep 21, 2023$0.03Oct 6, 2023recurring
Jun 27, 2023$0.03Jul 14, 2023recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Apr 18, 20064-for-3forward split
Apr 18, 20052-for-1forward split
Apr 19, 20043-for-2forward split
Apr 14, 20033-for-2forward split